{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:25:18Z","timestamp":1792697118322,"version":"4.5.0"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Incidence of Candida species increased in critically ill COVID-19 patients in intensive care units. This study aimed to investigate the impact of the COVID-19 pandemic on antifungal consumption and Candida species distribution in bloodstream infections. We observed that a significant increase in non-albicansCandida species cases (P\u00a0=\u00a0.005) in 2021 coincided with higher rates of fluconazole resistance (P\u00a0=\u00a0.002) and increased minimum inhibitory concentrations for echinocandins (P\u00a0=\u00a0.012). Notably, voriconazole consumption and increased MIC levels positively correlated with both Candida albicans and non-albicansCandida species. This study underscores the importance of judicious antifungal use during the COVID-19 pandemic.<\/jats:p>","DOI":"10.1093\/mmy\/myaf002","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T02:34:19Z","timestamp":1736994859000},"source":"Crossref","is-referenced-by-count":4,"title":["The impact of the COVID-19 on the antifungal consumption and antifungal resistance in <i>Candida<\/i> species isolated from the blood cultures of critically ill patients in intensive care units"],"prefix":"10.1093","volume":"63","author":[{"given":"Emre","family":"Kara","sequence":"first","affiliation":[{"name":"Hacettepe University Faculty of Pharmacy, Department of Clinical Pharmacy , Ankara ,","place":["Turkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Metan","sequence":"additional","affiliation":[{"name":"Hacettepe University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology , Ankara ,","place":["Turkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolunay","family":"G\u00fclmez","sequence":"additional","affiliation":[{"name":"Hacettepe University Faculty of Medicine, Department of Medical Microbiology , Ankara ,","place":["Turkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevtap","family":"Arikan-Akdagli","sequence":"additional","affiliation":[{"name":"Hacettepe University Faculty of Medicine, Department of Medical Microbiology , Ankara ,","place":["Turkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"issue":"5","key":"2025030418401541600_bib1","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/myc.13431","article-title":"Incidence and risk factors for COVID-19 associated candidemia (CAC) in ICU patients","volume":"65","author":"Kayaaslan","year":"2022","journal-title":"Mycoses"},{"issue":"1","key":"2025030418401541600_bib2","first-page":"75","article-title":"First confirmed cases of 2019 novel coronavirus in a university hospital in Turkey: housemate internists","volume":"52","author":"Uyaro\u011flu","year":"2021","journal-title":"Acta Medica"},{"key":"2025030418401541600_bib3"},{"issue":"7","key":"2025030418401541600_bib4","first-page":"382","article-title":"How antibiotics predispose to candidiasis","volume":"20","author":"Hofer","year":"2022","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"2025030418401541600_bib5","doi-asserted-by":"crossref","first-page":"otad010","DOI":"10.1093\/crocol\/otad010","article-title":"Corticosteroids increase the risk of invasive fungal infections more than tumor necrosis factor-alpha inhibitors in patients with inflammatory bowel disease","volume":"5","author":"Gregory","year":"2023","journal-title":"Crohns Colitis"},{"issue":"7","key":"2025030418401541600_bib6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/myc.13466","article-title":"A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic","volume":"65","author":"Er","year":"2022","journal-title":"Mycoses"},{"key":"2025030418401541600_bib7","first-page":"Doc15","article-title":"The impact of COVID-19 pandemic on nosocomial multidrug-resistant bacterial bloodstream infections and antibiotic consumption in a tertiary care hospital","volume":"17","author":"Metan","year":"2022","journal-title":"GMS Hyg Infect Control"},{"issue":"9","key":"2025030418401541600_bib8","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3390\/jof7090691","article-title":"The emergence of echinocandin-resistant Candida glabrata exhibiting high MICs and related FKS mutations in Turkey","volume":"7","author":"Sig","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"2025030418401541600_bib9","volume-title":"The Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). Method for the Determination of Broth Dilution Minimum Inhibitory Concentrations ofAntifungal Agents for Yeasts;\u00a0EUCAST Definitive Document E.DEF 7.3.2","author":"Arendrup","year":"2020"},{"key":"2025030418401541600_bib10","volume-title":"European Committee on Antimicrobial Susceptibility Testing Breakpoint Tables for Interpretation of MICs for Antifungal Agents","author":"EUCAST","year":"2020","edition":"10.0 edn"},{"issue":"11","key":"2025030418401541600_bib11","doi-asserted-by":"crossref","first-page":"e70000","DOI":"10.1111\/myc.70000","article-title":"Multicentre study of Candida parapsilosis blood isolates in T\u00fcrkiye highlights an increasing rate of fluconazole resistance and emergence of echinocandin and multidrug resistance","volume":"67","author":"\u00dcnal","year":"2024","journal-title":"Mycoses"},{"issue":"6","key":"2025030418401541600_bib12","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/jac\/dkad112","article-title":"Whole-genome sequencing confirms a persistent candidaemia clonal outbreak due to multidrug-resistant Candida parapsilosis","volume":"78","author":"Daneshnia","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"2025030418401541600_bib13","doi-asserted-by":"crossref","first-page":"676177","DOI":"10.3389\/fcimb.2021.676177","article-title":"Clonal candidemia outbreak by Candida parapsilosis carrying Y132F in Turkey: evolution of a persisting challenge","volume":"11","author":"Arastehfar","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"2025030418401541600_bib14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/myc.13296","article-title":"Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: increase in fluconazole resistance in 21 years","volume":"64","author":"Demirci-Duarte","year":"2021","journal-title":"Mycoses"},{"issue":"1","key":"2025030418401541600_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.5578\/tt.20219918","article-title":"Is COVID-19 a risk factor for invasive pulmonary aspergillosis in critically ill patients?","volume":"69","author":"Er","year":"2021","journal-title":"Tuberk Toraks"},{"issue":"3","key":"2025030418401541600_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/jof6030163","article-title":"Pan-echinocandin-resistant Candida glabrata bloodstream infection complicating COVID-19: a fatal case report","volume":"6","author":"Posteraro","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"5","key":"2025030418401541600_bib17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/cid\/ciab562","article-title":"The landscape of candidemia during the coronavirus disease 2019 (COVID-19) pandemic","volume":"74","author":"Seagle","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2025030418401541600_bib18","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/AAC.02603-14","article-title":"In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei","volume":"58","author":"Ricardo","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2025030418401541600_bib19","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s13054-022-04270-z","article-title":"Impact of COVID-19 pandemic on antifungal consumption: a multicenter retrospective analysis","volume":"26","author":"Bienvenu","year":"2022","journal-title":"Critical Care"},{"issue":"7","key":"2025030418401541600_bib20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3390\/jof9070769","article-title":"The impact of COVID-19 on the epidemiology and outcomes of candidemia: a retrospective study from a tertiary care center in Lebanon","volume":"9","author":"El\u00a0Zakhem","year":"2023","journal-title":"J Fungi"}],"container-title":["Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mmy\/advance-article-pdf\/doi\/10.1093\/mmy\/myaf002\/61445198\/myaf002.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/2\/myaf002\/61445198\/myaf002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mmy\/article-pdf\/63\/2\/myaf002\/61445198\/myaf002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T20:47:00Z","timestamp":1741121220000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mmy\/article\/doi\/10.1093\/mmy\/myaf002\/7954730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1,25]]}},"URL":"https:\/\/doi.org\/10.1093\/mmy\/myaf002","relation":{},"ISSN":["1369-3786","1460-2709"],"issn-type":[{"value":"1369-3786","type":"print"},{"value":"1460-2709","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2025,1,15]]},"article-number":"myaf002"}}